| Sign In to gain access to subscriptions and/or personal tools. |
Treatment of Diabetic Neuropathy with Pentoxifylline: Case ReportClinical Professor of Medicine, UCLA Medical Center, Los Angeles, CA
Assistant Clinical Professor of Medicine, UCLA Medical Center, Los Angeles, California
Professor of Neurology, UCLA Medical Center, Los Angeles, California
Clinical Instructor in Medicine, Los Angeles, California Diabetic neuropathy includes a heterogenous group of neuropathic syndromes associated with diabetes mellitus. One form of diabetic neuropathy is distal symmetric polyneuropathy, which is characterized at a late stage by intractable pain. This pain is generally refractory to present modalities of therapy except for narcotics. Pentoxifylline offers a new approach to therapy, reducing the blood viscosity and improving perfusion of ischemic microcirculation. A case report will be presented of intractable painful peripheral neuropathy responding dramatically to pentoxifylline therapy.
Angiology, Vol. 39, No. 4,
371-374 (1988) This article has been cited by other articles:
|
|||||||||||||||||||||||||||
